Healthcare >> CEO Interviews >> October 12, 2001
NATHANIEL DAVID was primarily responsible for assembling Syrrx, Inc.,
and currently serves as Syrrx's Director of Business Development. Dr.
David received his AB in Biology and Biochemistry from Harvard College
(1990) and his PhD in Molecular and Cellular Biology from the University
of California, Berkeley (1998). As one of the earliest employees of Cell
Genesys, Inc., Dr. David was one of the Genetic Engineers responsible
for developing the XenoMouse_, a transgenic animal now marketed by
Abgenix, Inc. During his doctoral work, Dr. David developed novel
methods for the production, purification, and crystallization of cell-
surface receptors. Profile
investors should be aware of?
Dr. David: In the aggregate, we've raised approximately $80 million in
various forms of
